Yava Saktu with Takra in Madhumeha (Diabetes Mellitus type 2)

A clinical study on the effectiveness of Yava Saktu with Takra in Madhumeha (Diabetes Mellitus type 2)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021065

Enrollment

Registered

2019-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: yava Sakthu with Takra in Madhumeha (Diabetes Mellitus type 2): The trial group will be advised with Yava- 20gm Takra-200ml twice daily for 30 days after food Control Intervention1: Ant

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of DM (Type-2) having blood sugar with the range of FBS â?? 120-220 mg/dl PPBS :- 180-280 mg/dl

Exclusion criteria

Exclusion criteria: Patients with complications will be excluded from the study. Insulin dependent subjects. Subjects with other systemic disorders such as P.C.O.D Thyroid Dysfunction. C.A Ischemic Heart Disease.

Design outcomes

Primary

Measure	Time frame
To study the effectiveness of Yava saktu with Takra in subjects with madhumeha (DM -II) Timepoint: The subjects are assessed by analyzing the objective criteria through blood investigation on baseline treatment, 15th day and on 30th day	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: The subjects are assessed by analyzing the objective criteria through blood investigation on baseline treatment, 15th day and on 30th day	—

Countries

India

Contacts

Public ContactDr Harisankar M S

Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan

yogaayu.guru@gmail.com9964620229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026